Thompson Davis & Co
CRVO icon

Thompson Davis & Co’s CervoMed CRVO Stock Holding History

Thompson Davis & Co’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.9K Sell
25,900
-3,850
-13% -$10.7K 0.05% 145
2026
Q2 		$92.2K Buy
29,750
+19,750
+198% +$69.6K 0.06% 154
2026
Q1 		$39.4K Hold
10,000
– – 0.03% 138
2025
Q4 		$79K Sell
10,000
-6,850
-41% -$55K 0.05% 138
2025
Q3 		$136K Buy
16,850
+2,900
+21% +$24.9K 0.08% 127
2025
Q2 		$87.7K Buy
+13,950
New +$119K 0.06% 117

Other funds holding CRVO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
SM
Sabby Management Miami Beach, Florida $9.02M AUM 74.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Byrne Asset Management
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
Savvy Advisors Inc
Savvy Advisors Inc New York $6.03B AUM 17.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Thompson Davis & Co's CRVO Position: Q3 2026 in Review

Thompson Davis & Co reduced its CervoMed (CRVO) stake by 13% in Q3 2026, selling an estimated $10.7K and leaving 25,900 shares worth $76.9K. The position accounts for 0.05% of the portfolio, ranked #145.

Thompson Davis & Co first reported a position in CRVO in Q2 2025 and has held it in 6 quarters since. The position peaked at $136K in Q3 2025. 28 funds tracked by Wall St. Rank hold CRVO as of Q3 2026.

  • Thompson Davis & Co held 25,900 shares of CervoMed worth $76.9K as of Q3 2026.
  • Thompson Davis & Co sold 3,850 CervoMed shares in Q3 2026, an estimated $10.7K.
  • CervoMed made up 0.05% of Thompson Davis & Co's portfolio in Q3 2026, its #145 holding.
  • Thompson Davis & Co first reported a position in CervoMed in Q2 2025 and has held it in 6 quarters since.
  • Thompson Davis & Co's CervoMed position peaked at $136K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held CervoMed as of Q3 2026.

Based on Thompson Davis & Co's 13F filing for Q3 2026, filed 5 Nov 2026.